Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
ATMARINOMED6
Mon, 11.05.2026       Marinomed Biotech AG

 Marinomed Biotech AG announces progress with Tacrolimus Eyedrops for Entry into the Compounding Market Strategic Commercial Milestone: Marinomed has chosen its first product for the compounding market, Tacrolimus eyedrops. First revenues from partners are expected for Q4/2026 or beginning of 2027. Strong Clinical Validation: Feedback from a glob [ … ]
Mon, 23.03.2026       Marinomed Biotech AG

Company Name: Marinomed Biotech AG ISIN: ATMARINOMED6   Reason for the research: Capital increase and 2025 prelims Recommendation: Buy from: 23.03.2026 Target price: €50 Target price on sight of: 12 months Last rating change: - Analyst: Alexander Rihane First Berlin Equity Research has published a research update on Marinom [ … ]

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

© 2026 Select Sector SPDRs

* * *

More Sector related Investment Ideas
© 2026 WEBs Investments ETFs
Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Tuesday, 26.05.2026, Calendar Week 22, 146th day of the year, 219 days remaining until EoY.